Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
101.8 ILa | 0.00% | 0.00% | -19.97% |
2023 | Nextgen Biomed Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Nextgen Biomed Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Business Summary
Number of employees: 15
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 20/22/20 | |
Dalia Mulakandov
DFI | Director of Finance/CFO | 39 | 17/23/17 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 08/00/08 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Grossman
BRD | Director/Board Member | 49 | 12/22/12 |
Yaacov Amidror
CHM | Chairman | 76 | 07/21/07 |
Alon Pinkas
BRD | Director/Board Member | 62 | 17/22/17 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 08/00/08 |
Tom Shabat
BRD | Director/Board Member | 35 | 06/22/06 |
Ilana Eldan
BRD | Director/Board Member | 43 | 18/22/18 |
Jacob Kaul
BRD | Director/Board Member | 74 | 17/22/17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 7,431,276 | 6,861,089 ( 92.33 %) | 0 | 92.33 % |
Company contact information
Nextgen Biomed Ltd.
P. O. Box 4318
, Raanana
+
Sector
1st Jan change | Capi. | |
---|---|---|
-19.97% | 22.07L | |
+9.66% | 2.74TCr | |
-29.70% | 317.62Cr | |
-16.08% | 252.63Cr | |
+19.05% | 249.37Cr | |
+11.11% | 216.07Cr | |
-4.24% | 202.6Cr | |
+5.56% | 160.53Cr | |
+3.25% | 130.62Cr | |
+29.73% | 129.22Cr |
- Stock Market
- Equities
- NXGN Stock
- Company Nextgen Biomed Ltd